Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

María Chaparro

Showing results (1-10 of 250) with videos related to

Pageof 25
Sort By:
Gastroenterologia Y Hepatologia|October 29, 2013
[New advances in the treatment of inflammatory bowel disease]María Chaparro
Gastroenterologia Y Hepatologia|February 15, 2012
[Advances in the management of ulcerative colitis presented at Digestive Disease Week 2011]María Chaparro
Gastroenterologia Y Hepatologia|September 29, 2012
[Advances in the efficacy, optimization and safety of treatments for inflammatory bowel disease]María Chaparro
Gastroenterologia Y Hepatologia|November 2, 2015
[Natural history, complications, safety and pregnancy in inflammatory bowel disease]María Chaparro
Gastroenterologia Y Hepatologia|October 9, 2014
[What useful developments for my inflammatory bowel disease practice have come from Digestive Disease Week 2014?]María Chaparro
Gastroenterologia Y Hepatologia|November 28, 2016
Treatment of inflammatory bowel disease: what's new in Digestive Disease Week 2016María Chaparro
Journal of Crohn'S & Colitis|January 18, 2023
Vaccines in Children Exposed to Biological Agents In Utero and/or During Breastfeeding: Are They Effective and Safe?Javier P Gisbert, María Chaparro
Journal of Crohn'S & Colitis|September 3, 2025
Combination therapy with biologics and/or small molecules in inflammatory bowel disease: a comprehensive reviewJavier P Gisbert, María Chaparro
Journal of Clinical Medicine|November 27, 2021
Primary Failure to an Anti-TNF Agent in Inflammatory Bowel Disease: Switch (to a Second Anti-TNF Agent) or Swap (for Another Mechanism of Action)?Javier P Gisbert, María Chaparro
Gastroenterologia Y Hepatologia|March 12, 2022
Tips and guidelines for being a good peer reviewerJavier P Gisbert, María Chaparro
Pageof 25

Showing results (1-10 of 250) with videos related to

Sort By:
Pageof 25
Gastroenterologia Y Hepatologia|October 29, 2013
[New advances in the treatment of inflammatory bowel disease]María Chaparro
Gastroenterologia Y Hepatologia|February 15, 2012
[Advances in the management of ulcerative colitis presented at Digestive Disease Week 2011]María Chaparro
Gastroenterologia Y Hepatologia|September 29, 2012
[Advances in the efficacy, optimization and safety of treatments for inflammatory bowel disease]María Chaparro
Gastroenterologia Y Hepatologia|November 2, 2015
[Natural history, complications, safety and pregnancy in inflammatory bowel disease]María Chaparro
Gastroenterologia Y Hepatologia|October 9, 2014
[What useful developments for my inflammatory bowel disease practice have come from Digestive Disease Week 2014?]María Chaparro
Gastroenterologia Y Hepatologia|November 28, 2016
Treatment of inflammatory bowel disease: what's new in Digestive Disease Week 2016María Chaparro
Journal of Crohn'S & Colitis|January 18, 2023
Vaccines in Children Exposed to Biological Agents In Utero and/or During Breastfeeding: Are They Effective and Safe?Javier P Gisbert, María Chaparro
Journal of Crohn'S & Colitis|September 3, 2025
Combination therapy with biologics and/or small molecules in inflammatory bowel disease: a comprehensive reviewJavier P Gisbert, María Chaparro
Journal of Clinical Medicine|November 27, 2021
Primary Failure to an Anti-TNF Agent in Inflammatory Bowel Disease: Switch (to a Second Anti-TNF Agent) or Swap (for Another Mechanism of Action)?Javier P Gisbert, María Chaparro
Gastroenterologia Y Hepatologia|March 12, 2022
Tips and guidelines for being a good peer reviewerJavier P Gisbert, María Chaparro
Pageof 25